Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-137
Closed -$11.5K 512
2024
Q4
$11.5K Buy
+137
New +$10.1K 0.01% 269

Other funds holding DXCM

Hurley Capital's DXCM Position: Q1 2025 in Review

Hurley Capital sold out of DexCom (DXCM) in Q1 2025, closing a stake of 137 shares — an estimated $11.5K sold.

Hurley Capital first reported a position in DXCM in Q4 2024 and held it in 1 quarter. The position peaked at $11.5K in Q4 2024. 932 funds tracked by Wall St. Rank hold DXCM as of Q1 2025.

  • Hurley Capital reported no remaining DexCom position as of Q1 2025 after selling out during the quarter.
  • Hurley Capital sold 137 DexCom shares in Q1 2025, an estimated $11.5K.
  • Hurley Capital first reported a position in DexCom in Q4 2024 and held it in 1 quarter.
  • Hurley Capital's DexCom position peaked at $11.5K in Q4 2024.
  • 932 funds tracked by Wall St. Rank held DexCom as of Q1 2025.

Based on Hurley Capital's 13F filing for Q1 2025, filed 7 May 2025.